Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients.
about
Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Interleukin 8 activity influen ...... unotherapy in cancer patients.
@en
Interleukin 8 activity influen ...... unotherapy in cancer patients.
@nl
type
label
Interleukin 8 activity influen ...... unotherapy in cancer patients.
@en
Interleukin 8 activity influen ...... unotherapy in cancer patients.
@nl
prefLabel
Interleukin 8 activity influen ...... unotherapy in cancer patients.
@en
Interleukin 8 activity influen ...... unotherapy in cancer patients.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Interleukin 8 activity influen ...... unotherapy in cancer patients.
@en
P2093
Anniina Koski
Ilkka Liikanen
Kristian Taipale
Matti Kankainen
Päivi Pakarinen
Riikka Havunen
Riitta Koivisto-Korander
Siri Tähtinen
P2860
P304
P356
10.18632/ONCOTARGET.23967
P407
P577
2018-01-05T00:00:00Z